China Pharma Holdings, Inc. (CPHI) vs Rockwell Medical, Inc. (RMTI)

China Pharma Holdings, Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. China Pharma Holdings, Inc. and Rockwell Medical, Inc. are of similar size ($34.5M and $31.8M). China Pharma Holdings, Inc. grew revenue faster over the last twelve months: −11.0% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −114.3%) and the lower return on invested capital (−14.6% vs −7.23%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 11 and China Pharma Holdings, Inc. on 7.

Valuation

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 7.76 0.48 2.25
P/B 0.84 0.95 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 8.52 0.25 2.56
Earnings yield (57.33%) (15.95%) (2.99%)
Free cash flow yield (1.10%) (2.95%) 0.00%

Profitability

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
Gross margin 11.76% 17.71% 53.94%
Operating margin (111.84%) (6.52%) 0.00%
Net margin (114.33%) (7.33%) 0.00%
Free cash flow margin (3.59%) 2.47% 0.00%
Return on equity (20.99%) (15.53%) (0.40%)
Return on assets (15.30%) (9.32%) (3.32%)
Return on invested capital (7.23%) (14.58%) 0.00%

Growth

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.97%) (21.12%) 10.01%
EPS growth (last fiscal year) 72.59% (870.87%) —
Revenue growth, 5-year CAGR (17.53%) 2.17% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.26 0.05
Current ratio 0.26 3.25 2.31
Net debt to EBITDA (0.98) 7.40 0.85

Dividend

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CPHI RMTI Drug Manufacturers Specialty & Generic median
Market cap 31.83m 34.54m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack